Gene editing in model organisms has provided critical insights into brain development and diseases. Here, we report the generation of a cynomolgus monkey (Macaca fascicularis) carrying MECP2 mutations using transcription activator-like effector nucleases (TALENs)-mediated gene targeting. After injecting TALENs mRNA into monkey zygotes achieved by in vitro fertilization and embryo transplantation into surrogate monkeys, we obtained one male newborn monkey with an MECP2 deletion caused by frameshifting mutation in various tissues. The monkey carrying the MECP2 mutation failed to survive after birth, due to either the toxicity of TALENs or the critical requirement of MECP2 for neural development. The level of MeCP2 protein was essentially depleted in the monkey's brain. This study demonstrates the feasibility of introducing genetic mutations in non-human primates by site-specific gene-editing methods.
INTRODUCTION
Model organisms with genetic manipulations have proven to be valuable tools for understanding brain development and diseases. Gene editing in non-human primates would be particularly valuable for studying neuropsychiatric diseases with symptoms that are difficult to identify in rodents and other model organisms [1] . Recently, site-specific geneediting methods, such as the use of transcription activatorlike effector nucleases (TALENs) and the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated protein (Cas9) system, have been developed for gene editing in various organisms, including worms, fi sh, and rodents [2] [3] [4] [5] [6] [7] . Two recent studies have successfully generated monkeys with genetic mutations via the CRISPR/Cas9 or TALEN methods [8, 9] The gene methyl-CpG binding protein 2 (MECP2) encodes a methyl-DNA-binding protein, and mutations of this gene in humans lead to Rett syndrome, a severe neurodevelopmental disorder [10, 11] . Not only does MeCP2 play a critical role in regulating gene expression transcriptionally, it also controls nuclear microRNA processing and regulates gene expression via microRNAs [12] [13] [14] . Mice with mecp2 deletion appear to have severe health issues and mimic human patients with Rett syndrome [15, 16] . However, whether the loss of MECP2 in non-human primates yields similar
outcomes is yet to be determined.
In this study, we used TALEN-based methods to introduce mutations in the MECP2 gene and acquired a male monkey carrying these mutations, but it failed to survive after birth. We found that this monkey carried MECP2 mutations in various tissues and the MeCP2 protein level in the brain was significantly decreased compared to that of wild-type monkeys. This result suggests that loss of MECP2 in primates may still allow the full development of the brain and provides a useful path through which we can understand the role of MeCP2 in primate brain development.
MATERIALS AND METHODS
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Design and Validation of TALENs
A total of 10 TALENs were designed against exon 3 of the monkey MECP2 gene by the Beijing Biocytogen Co. Ltd., using the TALEN GoldenGate system (Figs. S1 and S2).
TALENs were transfected into COS7 cells and the PCR products, amplifi ed by primers (F: gcctcattgagcattcattc, R: cctatagaggcaggagttgctc), were sequenced. Overlapped peaks from sequencing results were found and indicated that the TALENs were active. TALEN #52 was chosen for injection into monkey zygotes.
Production of TALEN mRNA
The TALEN plasmid was digested by the AflII restriction enzyme. The digested product was gel-purifi ed and used as the template for in vitro transcription using the mMESSAGE mMACHINE T7 kit (#AM1344; Life Technologies, Shanghai, China). Both TALEN-52L and TALEN-52R mRNAs were purified by phenol-chloroform extraction and isopropanol precipitation.
Collection of Oocytes, Gene Delivery, and Embryo
Construction
Oocytes were collected at laparoscopy by aspiration from follicles 2-8 mm in diameter, 32-36 h after stimulation with human chorionic gonadotropin [17, 18] . The collected oocytes were cultured in pre-equilibrated maturation medium [17] . Monkey semen was collected by penile electroejaculation. Oocytes arrested in metaphase II were selected for intracytoplasmic sperm injection (ICSI). For ICSI, a single sperm was immobilized and aspirated tailfi rst. A single oocyte was fi xed by a holding pipette, and the injection pipette was pushed through the zona pellucida and subsequently through the oolemma to release the spermatozoon [17] . After ICSI, zygotes were cultured in preequilibrated hamster embryo culture medium 9 at 37°C under 5% CO 2 for 6-8 h, and then selected for injection of TALEN mRNA at 25 or 12.5 ng/μL.
Selection of Surrogate Females and Embryo Transfer
The menstrual cycles of females were recorded daily. To synchronize the developmental stage of embryos with the recipient, monkeys were chosen for tubal embryo transfer at 0-3 days after ovulation, and a stigma or a new corpus luteum on the ovary was observed at laparoscopy. One to six embryos at pronuclear stage were selected for tubal transfer to each surrogate female [18] .
Genotyping PCR
DNA was extracted from small samples of various tissues collected from newborn monkeys. Samples were digested with proteinase K overnight at 65°C and precipitated for DNA and PCR with specific primers against monkey MECP2 as follows: MK-Mecp2-F:
CTTGTCAGCCATTGAGCCCAGAG and MK-Mecp2-R:
AGCTTCCGTGTCCAGCCTTCA. PCR products were sequenced for MECP2 mutations.
Immunohistochemistry of Transgenic Monkey Tissues
Stillborn MECP2 mutant and wild-type (WT) monkeys were deeply anaesthetized with ketamine hydrochloride 
RESULTS AND DISCUSSION
To delete the MECP2 gene from the monkey genome, we decided to target exon 3, which is one of two major coding exons in this gene (Fig. 1A) . We synthesized 10 TALEN pairs and tested their efficiency by transfecting them into COS7 monkey cells (Fig. S1A) . After sequencing the MECP2 gene in the COS7 cells expressing various TALENs, we found that TALEN #52 successfully introduced genomic deletions (Fig. S1B) . The complete targeting module of TALEN #52 is shown in Fig. S2 (see also Fig. 
1A, B).
We then injected the mRNA of TALEN #52 (12.5 ng/ μL) into 52 cynomolgus monkey zygotes obtained by intracytoplasmic sperm injection (Fig. 1C) , and transferred 51 embryos into 9 surrogate female monkeys. Three surrogates became pregnant and gave birth to 5 offspring (A, B1-3, and C; Table 1 ); all but one were stillborn. The low pregnancy and survival rates may refl ect the toxicity of TALEN mRNA. (Fig. 1D) . Monkey A (with the MECP2 deletion) failed to survive after birth, due to either the toxicity of TALENs or the critical requirement of MECP2 for embryonic development, as suggested by the lethality of male human fetuses with MECP2 mutations [10] . Mutations were found in all tissues of monkey A examined: heart, kidney, muscle, cerebral cortex, cerebellum, and liver ( Fig.   S3A-F) . Furthermore, these mutations in the MECP2 gene appeared to be mosaic within each tissue, showing overlapped signals of wild-type and mutated sequences ( Fig. S3A-F) . Therefore, we examined the mutation rate of the MECP2 gene by sequencing genomic DNA from various tissues and found that the highest mutation rates, >30%, were in the cerebrum and liver (Fig. 1E ). This mosaicism may be due to the delayed activity of TALENs in monkey zygotes, similar to that found in TALEN-mediated gene targeting in mouse and rat [2, 4] .
To determine whether the level of MeCP2 protein was altered by the genomic deletion caused by TALENs, we performed Western blotting analysis using cortical tissues from monkeys A (with the MECP2 deletion), B2, and B3 and found that the level was largely depleted only in the lysate from monkey A (Fig. 1F) . Further immunohistochemical study of the MeCP2 expression in brain sections showed that MeCP2 staining was detectable in monkey B1 but not in monkey A (Fig. 1G) . Thus, the level of MeCP2 protein was essentially depleted in the monkey with the MECP2 mutation.
In summary, we have shown that the TALEN method can be used to generate monkeys with a specific gene A recent study reported that investigators obtained a female cynomolgus monkey with MECP2 mutations using the TALEN-based gene-editing method [8] . But male monkeys carrying MECP2 mutations in the study failed to 
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